Authors:
IBEANU GC
BLAISDELL J
GHANAYEM BI
BEYELER C
BENHAMOU S
BOUCHARDY C
WILKINSON GR
DAYER P
DALY AK
GOLDSTEIN JA
Citation: Gc. Ibeanu et al., AN ADDITIONAL DEFECTIVE ALLELE, CYP2C19-ASTERISK-5, CONTRIBUTES TO THE S-MEPHENYTOIN POOR METABOLIZER PHENOTYPE IN CAUCASIANS, Pharmacogenetics, 8(2), 1998, pp. 129-135
Citation: Ke. Thummel et Gr. Wilkinson, IN-VITRO AND IN-VIVO DRUG-INTERACTIONS INVOLVING HUMAN CYP3A, Annual review of pharmacology and toxicology, 38, 1998, pp. 389-430
Authors:
FERGUSON RJ
DEMORAIS SMF
BENHAMOU S
BOUCHARDY C
BLAISDELL J
IBEANU G
WILKINSON GR
SARICH TC
WRIGHT JM
DAYER P
GOLDSTEIN JA
Citation: Rj. Ferguson et al., A NEW GENETIC-DEFECT IN HUMAN CYP2C19 - MUTATION OF THE INITIATION CODON IS RESPONSIBLE FOR POOR METABOLISM OF S-MEPHENYTOIN, The Journal of pharmacology and experimental therapeutics, 284(1), 1998, pp. 356-361
Citation: Gr. Wilkinson, THE BLESSINGS OF WAR - THE DEPICTION OF MILITARY FORCE IN EDWARDIAN NEWSPAPERS, Journal of contemporary history, 33(1), 1998, pp. 97-115
Authors:
KIM RB
FROMM MF
WANDEL C
LEAKE B
WOOD AJJ
RODEN DM
WILKINSON GR
Citation: Rb. Kim et al., THE DRUG TRANSPORTER P-GLYCOPROTEIN LIMITS ORAL ABSORPTION AND BRAIN ENTRY OF HIV-1 PROTEASE INHIBITORS, The Journal of clinical investigation, 101(2), 1998, pp. 289-294
Authors:
ADEDOYIN A
ARNS PA
RICHARDS WO
WILKINSON GR
BRANCH RA
Citation: A. Adedoyin et al., SELECTIVE EFFECT OF LIVER-DISEASE ON THE ACTIVITIES OF SPECIFIC METABOLIZING ENZYMES - INVESTIGATION OF CYTOCHROMES P450 2C19 AND 2D6, Clinical pharmacology and therapeutics, 64(1), 1998, pp. 8-17
Citation: E. Delaporte et Gr. Wilkinson, MODULATION OF CYTOCHROME-P450 ENZYME-ACTIVITY BY RESVERATROL, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 48-48
Citation: D. Oshea et al., MODULATION OF CYP2EI ACTIVITY BY ISONIAZID IN RAPID AND SLOW N-ACETYLATORS, British journal of clinical pharmacology, 43(1), 1997, pp. 99-103
Citation: Gr. Wilkinson, THE EFFECTS OF DIET, AGING AND DISEASE-STATES ON PRESYSTEMIC ELIMINATION AND ORAL-DRUG BIOAVAILABILITY IN HUMANS, Advanced drug delivery reviews, 27(2-3), 1997, pp. 129-159
Citation: H. Takahashi et al., CHARACTERIZATION OF THE HEPATIC CANALICULAR MEMBRANE-TRANSPORT OF A MODEL OLIGOPEPTIDE - DITEKIREN, The Journal of pharmacology and experimental therapeutics, 281(1), 1997, pp. 297-303
Authors:
ARNS PA
ADEDOYIN A
DIBISCEGLIE AM
WAGGONER JG
HOOFNAGLE JH
WILKINSON GR
BRANCH RA
Citation: Pa. Arns et al., MEPHENYTOIN DISPOSITION AND SERUM BILE-ACIDS AS INDEXES OF HEPATIC-FUNCTION IN CHRONIC VIRAL-HEPATITIS, Clinical pharmacology and therapeutics, 62(5), 1997, pp. 527-537
Authors:
DARBAR D
DELLORTO S
MORIKE K
WILKINSON GR
RODEN DM
Citation: D. Darbar et al., DIETARY SALT INCREASES FIRST-PASS ELIMINATION OF ORAL QUINIDINE, Clinical pharmacology and therapeutics, 61(3), 1997, pp. 292-300
Citation: Rb. Kim et al., HIGH-AFFINITY UPTAKE BY ISOLATED RAT HEPATOCYTES OF A LINEAR PSEUDO-HEXAPEPTIDE, DITEKIREN, Biochimica et biophysica acta. Biomembranes, 1328(1), 1997, pp. 41-47
Authors:
WANDEL C
NEFF S
KEPPLER G
BOHRER H
STOCKINGER K
WILKINSON GR
WOOD M
MARTIN E
Citation: C. Wandel et al., THE RELATIONSHIP BETWEEN CYTOCHROME P4502E1 ACTIVITY AND PLASMA FLUORIDE LEVELS AFTER SEVOFLURANE ANESTHESIA IN HUMANS, Anesthesia and analgesia, 85(4), 1997, pp. 924-930
Authors:
DARBAR D
DELLORTO S
WILKINSON GR
RODEN DM
Citation: D. Darbar et al., LOSS OF QUINIDINE GLUCONATE INJECTION IN A POLYVINYL-CHLORIDE INFUSION SYSTEM, American journal of health-system pharmacy, 53(6), 1996, pp. 655-658
Citation: Rb. Kim et Gr. Wilkinson, CYP2E1 ACTIVITY IS NOT ALTERED BY INFLUENZA VACCINATION, British journal of clinical pharmacology, 42(4), 1996, pp. 529-530
Citation: Rj. Herman et Gr. Wilkinson, DISPOSITION OF DIAZEPAM IN YOUNG AND ELDERLY SUBJECTS AFTER ACUTE ANDCHRONIC DOSING, British journal of clinical pharmacology, 42(2), 1996, pp. 147-155
Citation: Gr. Wilkinson, CYTOCHROME P4503A (CYP3A) METABOLISM - PREDICTION OF IN-VIVO ACTIVITYIN HUMANS, Journal of pharmacokinetics and biopharmaceutics, 24(5), 1996, pp. 475-490
Authors:
KIM RB
YAMAZAKI H
CHIBA K
OSHEA D
MIMURA M
GUENGERICH FP
ISHIZAKI T
SHIMADA T
WILKINSON GR
Citation: Rb. Kim et al., IN-VIVO AND IN-VITRO CHARACTERIZATION OF CYP2E1 ACTIVITY IN JAPANESE AND CAUCASIANS, The Journal of pharmacology and experimental therapeutics, 279(1), 1996, pp. 4-11
Citation: Y. Caraco et al., DIFFERENCES BETWEEN WHITE SUBJECTS AND CHINESE SUBJECTS IN THE IN-VIVO INHIBITION OF CYTOCHROME P450S 2C19, 2D6, AND 3A BY OMEPRAZOLE, Clinical pharmacology and therapeutics, 60(4), 1996, pp. 396-404
Authors:
THUMMEL KE
OSHEA D
PAINE MF
SHEN DD
KUNZE KL
PERKINS JD
WILKINSON GR
Citation: Ke. Thummel et al., ORAL FIRST-PASS ELIMINATION OF MIDAZOLAM INVOLVES BOTH GASTROINTESTINAL AND HEPATIC CYP3A-MEDIATED METABOLISM, Clinical pharmacology and therapeutics, 59(5), 1996, pp. 491-502